エンドモルフィンの代謝に基づく鎮痛薬の開発

概要

論文の詳細を見る
Endomorphin-2 (Tyr-Pro-Phe-PheNH_2) was discovered as an endogenous ligand for the μ-opioid receptor. The physiologic function of endomorphin-2 as a neurotransmitter or neuromodulator may cease after rapid enzymatic processing in the synapses of the brain, like other neuropeptides. The present study was conducted to examine the metabolism of endomorphin-2 by synaptic membranes prepared from mouse brain. Major metabolites were free tyro-sine, free phenylalanine, Tyr-Pro, and PheNH_2. Both the degradation of endomorphin-2 and the accumulation of major metabolites were inhibited by specific inhibitors of dipeptidyl peptidase IV, such as diprotin A and B. On the other hand, the accumulation of Phe-PheNH_2 and Pro-Phe-PheNH_2 was increased in the presence of bestatin, an aminopepti-dase inhibitor, whereas that of free phenylalanine and PheNH_2 was decreased. Furthermore, purified dipeptidyl pepti-dase IV hydrolyzed endomorphin-2 at the cleavage site, the Pro^2-Phe^3 bond. Thus degradation of endomorphin-2 by brain synaptic membranes appears to occur mainly through the cleavage of the Pro^2-Phe^3 bond by dipeptidyl peptidase IV, followed by the release of free phenylalanine and PheNH2 from the liberated fragment, Phe-PheNH2, by aminopep-tidase. We have also examined the effects of diprotin A on the antinociception induced by intracerebroventricularly administered endomorphin-2 in the mouse paw withdrawal test. Diprotin A simultaneously injected with endomorphin-2 enhanced endomorphin-2-induced antinociception. These results indicate that dipeptidyl peptidase IV may be an im-portant peptidase responsible for terminating endomorphin-2-induced antinociception at the supraspinal level in mice. These findings also suggest that selective dipeptidyl peptidase IV inhibitors or dipeptidyl peptidase IV-resistant en-domorphin-2 analogues have the potential for the clinical use as analgesics.
2004-08-01

著者

櫻田誓
第一薬科大学生化学教室

エンドモルフィンの代謝に基づく鎮痛薬の開発

スポンサーリンク

概要

著者

関連論文

スポンサーリンク